期刊
PHYTOTHERAPY RESEARCH
卷 27, 期 1, 页码 135-138出版社
WILEY-BLACKWELL
DOI: 10.1002/ptr.4685
关键词
Bacopa monnieri; Ginkgo biloba; cerebral blood flow; blood pressure; vasodilation; nootropic
资金
- National Research Council of Thailand
Bacopa monnieri (L.) Wettst. (Brahmi in India and Thailand) is an ayurvedic dementia treatment, but its effect on cerebral blood flow (CBF) is still unknown. We sought to test its chronic and acute effects on CBF compared with Ginkgo biloba and donepezil. CBF was measured by laser Doppler from rat cerebral cortex after 8 weeks of daily oral dosing of these drugs. Systolic blood pressure was also measured using the tail cuff method or via arterial cannulation. In rats treated with B. monnieri (40 mg/kg), CBF was 25% increased [2927 +/- 123 perfusion units, (PU)] compared with shams (2337 +/- 217PU, p < 0.05, nine rats). G. biloba (60 mg/kg) also increased CBF (by 29% to 3019 +/- 208 PU, p < 0.05, nine rats). No clear effect was obtained with donepezil (1 mg/kg). Chronic administration of the preparations had no effect on blood pressure. In contrast, intravenous acute infusion of these herbals (2060 mg/kg) had marked dose-dependent hypotensive actions (diastolic similar to 31 mmHg lower with 40 mg/kg of either extract), which correspondingly reduced CBF by similar to 15%. Likewise, CBF fell slightly with acute intravenous sodium nitroprusside and rose with noradrenaline. Donepezil (1 mg/kg) was slightly hypotensive without affecting CBF. Increased CBF with B. monnieri may account for its reported procognitive effect, and its further exploration as an alternative nootropic drug is worthwhile. Copyright (C) 2012 John Wiley & Sons, Ltd.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据